A plain language summary of the ASCENT study: Sacituzumab Govitecan for metastatic triple-negative breast cancer.

Sacituzumab Govitecan Trop-2 antibody–drug conjugate breast cancer lay summary plain language summary triple-negative breast cancer

Journal

Future oncology (London, England)
ISSN: 1744-8301
Titre abrégé: Future Oncol
Pays: England
ID NLM: 101256629

Informations de publication

Date de publication:
01 Oct 2021
Historique:
pubmed: 2 9 2021
medline: 21 10 2021
entrez: 1 9 2021
Statut: ppublish

Résumé

Sacituzumab Govitecan (also known by the brand name TRODELVY

Identifiants

pubmed: 34467774
doi: 10.2217/fon-2021-0868
doi:

Substances chimiques

Antibodies, Monoclonal, Humanized 0
Immunoconjugates 0
sacituzumab govitecan M9BYU8XDQ6
Camptothecin XT3Z54Z28A

Banques de données

ClinicalTrials.gov
['NCT02574455']

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

3911-3924

Commentaires et corrections

Type : CommentOn

Auteurs

Aditya Bardia (A)

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.

Sara A Hurvitz (SA)

University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.

Hope S Rugo (HS)

University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.

Adam Brufsky (A)

Magee-Women's Hospital and the Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Javier Cortes (J)

International Breast Cancer Center (IBCC), Quiron Group, Barcelona, Spain.

Sibylle Loibl (S)

Department of Medicine and Research, Hämatologisch-Onkologische Gemeinschaftspraxis am Bethanien-Krankenhaus, Frankfurt, Germany.

M Piccart (M)

Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium.

Janice Cowden (J)

Patient author.

Patty Spears (P)

Patient author.
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.

Lisa A Carey (LA)

Department of Medicine - Division of Hematology/Oncology, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH